Company Filing History:
Years Active: 2018
Title: David Lafargue: Innovator in Cardiac Treatment
Introduction
David Lafargue is a notable inventor based in Saint Jean le Blanc, France, recognized for his contributions to the field of medicinal chemistry. With a focus on innovations that address critical health issues, he has a patent that reflects significant advancements in cardiac treatments.
Latest Patents
Lafargue's sole patent is titled "Salt of ivabradine and process for the preparation thereof." This invention details the formulation of Ivabradine hemipamoate, along with its hydrates. The patent outlines the medicinal products that utilize this compound, emphasizing its utility in the treatment and prevention of various clinical situations associated with myocardial ischemia. These include conditions such as angina pectoris, myocardial infarction, and rhythm disturbances, particularly supraventricular rhythm disturbances, along with complications in systolic or diastolic heart failure.
Career Highlights
David Lafargue has made significant strides in his career at Les Laboratoires Servier, a reputable company known for its dedication to developing innovative pharmaceuticals. His work has contributed to vital therapies that aim to improve patient outcomes in cardiac health.
Collaborations
Throughout his career, Lafargue has collaborated with esteemed colleagues, notably Michael Lynch and Patrick Cointepas. These partnerships have fostered an environment of innovation and have amplified the impact of their collective research efforts in the medicinal field.
Conclusion
In summary, David Lafargue stands out as an influential inventor whose work in the cardiac treatment domain brings hope for patients facing serious heart-related conditions. His patent for Ivabradine hemipamoate showcases his commitment to advancing medical science and improving healthcare solutions. As part of Les Laboratoires Servier, he continues to play a critical role in shaping the future of cardiac medicines.